CD22 Exon 12 Deletion as an Independent Predictor of Poor Treatment Outcomes in B-ALL
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15051599
Abstract: Simple Summary We previously reported that cancer cells from the most common type of childhood cancer, namely, a form of acute leukemia known as B-ALL, are characterized by an abnormality known as CD22 exon 12… read more here.
Keywords: cd22; exon deletion; poor treatment; cd22 exon ... See more keywords